“I think the real legacy of Pharmacology will be that it is and will be recognized as a good first-course pharmacology textbook.” – Craig Stevens, PhD
I think the real legacy of Pharmacology will be that it is and will be recognized as a good first-course pharmacology textbook. It’s used in a number of medical schools, allied health science schools, nursing schools, and other places where health science students need an initial introduction to the principles and the mechanisms of drug action. So hopefully that’ll be a legacy that this book, by being just right — just in the middle, not too big, not too small — will leave behind as it continues to be used for many years to come.
This is a very dynamic field. Sometimes I wish I was writing a book about anatomy — that doesn’t change except over millions of years! The new drugs change very quickly. New drugs are added to the market; some are taken off because of adverse effects. So that’s been almost a necessary revision where every two or three years we’ve been fortunate enough to be able to revise Pharmacology. The second thing is the look of the book. It’s been updated — full, four-color art or figures — and so I think it’s a very handsome book, as far as appeal to the students to read the book; I think they’ll find it very exciting with some of the new updates in the figures.
Biography
Craig W. Stevens, PhD is a professor of pharmacology in the Department of Pharmacology and Physiology at Oklahoma State University-Center for Health Sciences in Tulsa. He is an expert in the field of opioid pharmacology, with particular interest in opioid receptor proteins and the role of opioids in neuroimmune interactions. He has authored numerous texts and has presented his research to audiences around the globe. He is a co-author of the fourth edition of Pharmacology.
Dr. Stevens holds a PhD in pharmacology from the Mayo Graduate School of Medicine, and an MS in biological sciences from the University of Illinois, Chicago. He is active in numerous professional societies, including the American Society for Pharmacology and Experimental Therapeutics, the International Narcotics Research Conference, the Society for Neuroscience, and the American Association for the Advancement of Science, among others. Dr. Stevens has been recipient of several awards, including the Young Investigator Travel award of the American Pain society, the NIDA Travel Award of INRC, the CPDD Travel Award, and the ASPET Young Scientist Travel Award. He is also the first recipient of the Regents Research Award at his institution.
Related Author: George M. Brenner, PhD
